Long lasting octreotide LAR therapy in non functioning pancreatic neuroendocrine carcinoma

Long lasting octreotide LAR therapy in non functioning pancreatic neuroendocrine carcinoma

Non functioning endocrine pancreatic tumors (NF-PETs) have absent or low hormone secretion without symptoms and constitue ~60% of PETs. At diagnosis more than 50% of patients have liver metastases and almost 40% are not candidates for radical surgery because of either locally advanced disease or unr...

Full description

Bibliographic Details
Main Authors: Ivan Lolli, Antonio Logroscino, Simona Vallarelli, Maria A. Monteduro, Antonella Gentile, Giuseppe Troccoli
Format: Article
Language:English
Published: SEEd 2015-10-01
Series:Clinical Management Issues
Subjects:
Non functioning metastatic endocrine tumour
Histological test
Somatostatin analogues
Online Access:https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1067

Internet

https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1067

Similar Items